K Lu Timothy is CEO and Interim PFO and PAO of Senti Biosciences, Inc.. Currently has a direct ownership of 724,440 shares of SNTI, which is worth approximately $2.49 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 642,358 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 724K
16.3% 3M change
16.3% 12M change
Total Value Held $2.49 Million

K Lu Timothy Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
BUY
Grant, award, or other acquisition
-
642,358 Added 47.0%
724,440 Common Stock
Feb 06 2025
SELL
Open market or private sale
$2,376 $4.36 p/Share
545 Reduced 0.66%
82,082 Common Stock
Feb 04 2025
SELL
Open market or private sale
$15,962 $4.07 p/Share
3,922 Reduced 4.53%
82,627 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
306,000 Added 26.12%
865,496 Common Stock
KLT

K Lu Timothy

CEO and Interim PFO and PAO
South San Francisco, CA

Track Institutional and Insider Activities on SNTI

Follow Senti Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SNTI shares.

Notify only if

Insider Trading

Get notified when an Senti Biosciences, Inc. insider buys or sells SNTI shares.

Notify only if

News

Receive news related to Senti Biosciences, Inc.

Track Activities on SNTI